SBI Leasing Services Co.,Ltd. Logo

SBI Leasing Services Co.,Ltd.

Structures Japanese Operating Leases for aircraft & ships for corporate investors.

5834 | T

Overview

Corporate Details

ISIN(s):
JP3163490000
LEI:
Country:
Japan
Address:
港区六本木一丁目6番1号 泉ガーデンタワー14階
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

SBI Leasing Services Co., Ltd., established in 2017, is a financial services firm specializing in structuring and providing Japanese Operating Lease (JOL) products for investments in real assets. The company purchases high-value assets, primarily commercial aircraft and ships, and leases them to global airlines and shipping companies. It creates investment funds based on these leases for corporate investors. Key products include the standard JOL and the JOLCO (Japanese Operating Lease with Call Option), which offer investors benefits such as distributed lease income, potential capital gains, and significant tax advantages like profit equalization and deferral.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-13 03:33
Registration Form
確認書
Japanese 8.2 KB
2025-11-13 03:30
Interim Report
半期報告書-第9期(2025/04/01-2026/03/31)
Japanese 167.4 KB
2025-10-31 08:00
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-10-28 05:51
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-06-30 08:36
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-06-30 08:24
Post-Annual General Meeting Information
臨時報告書
Japanese 24.0 KB
2025-06-24 03:34
Regulatory News Service
内部統制報告書-第8期(2024/04/01-2025/03/31)
Japanese 26.3 KB
2025-06-24 03:32
Regulatory News Service
確認書
Japanese 8.1 KB
2025-06-24 03:30
Annual Report
有価証券報告書-第8期(2024/04/01-2025/03/31)
Japanese 1.9 MB
2025-02-20 02:30
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 54.8 KB
2024-12-02 07:30
Registration Form
発行登録書(株券、社債券等)
Japanese 28.6 KB
2024-11-13 07:32
Report Publication Announcement
確認書
Japanese 8.1 KB
2024-11-13 07:30
Interim Report
半期報告書-第8期(2024/04/01-2025/03/31)
Japanese 180.2 KB
2024-10-04 08:40
Share Issue/Capital Change
訂正臨時報告書
Japanese 29.4 KB
2024-08-30 08:55
Share Issue/Capital Change
臨時報告書
Japanese 28.1 KB

Automate Your Workflow. Get a real-time feed of all SBI Leasing Services Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SBI Leasing Services Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SBI Leasing Services Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

VALIRX PLC Logo
Advancing oncology & women's health therapeutics and offering preclinical research services.
United Kingdom
VAL
VALUE GOLF Inc. Logo
A golf services hub offering reservations, solo player bookings, e-commerce, lessons, and tours.
Japan
3931
Value HR Co., Ltd. Logo
Offers a health management platform and consulting for corporate health insurance societies in Japan.
Japan
6078
Global OTA for curated tours & experiences, focusing on travel to and from Japan.
Japan
7048
A South Korean travel company offering global tour packages, flights, hotels, and corporate travel.
South Korea
094850
Virax Biolabs Group Ltd Logo
Specializes in T-cell immunity tests and diagnostics for profiling viral disease responses.
United States of America
VRAX
VisionSys AI Inc Logo
Develops AI-powered brain-computer interfaces for the healthcare and biotech sectors.
United States of America
VSA
Vivesto Logo
Develops and licenses novel cancer therapies for humans and animals using proprietary drug delivery.
Sweden
VIVE
Vor Biopharma Inc. Logo
Clinical-stage biotech developing next-gen medicines that target the root cause of autoimmune disease.
United States of America
VOR
Voronoi, Inc. Logo
Develops selective kinase inhibitors and targeted protein degraders for precision oncology.
South Korea
310210

Talk to a Data Expert

Have a question? We'll get back to you promptly.